Media Thread, page-6347

A bit strange behaviour, however, not surprising. I think Tin-tin has hit the nail on the head. Imagine working hard day in day out and finding out a company is potentially leaps and bounds ahead of what you're doing.

Although not the same, the head of oncology at a well-known hospital in Aus I know through a close contact of mine had no idea about IMU, their B-cell trials and/or the oncolytic virus trials they had going on only a few months ago. When I explained what they were doing, they were very surprised and shocked that it was an Australian-based company. This is by no means a comment against this person; however, it illustrates how little is known about IMU by those actually at the coal face of this terrible disease. In their own 'backyard' no less.

If these trials are successful, I have no doubt that it will change very quickly.

IMO DYOR